Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

<p>Phosphoproteins</p>

Shranjeno v:

Bibliografske podrobnosti
Glavni avtor:	Xiaoqing Cheng (16918496) (author)
Drugi avtorji:	Yirui Sun (16918499) (author), Maureen Highkin (16918502) (author), Nagalaxmi Vemalapally (16918505) (author), Xiaohua Jin (16918508) (author), Brandon Zhou (16918511) (author), Julie L. Prior (16918514) (author), Ashley R. Tipton (16918517) (author), Shunqiang Li (15123195) (author), Anton Iliuk (16918520) (author), Samuel Achilefu (11605234) (author), Ian S. Hagemann (15026769) (author), John R. Edwards (16918523) (author), Ron Bose (15045749) (author)
Izdano:	2025
Teme:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Biological Agents & Therapies Antibody-drug conjugates Antireceptors Breast Cancer Cell Cycle CDKs and CDK inhibitors Preclinical Models Organoids
Oznake:	Označite Brez oznak, prvi označite!

Opis
Izvleček:	<p>Phosphoproteins</p>

Cannot write session to /tmp/vufind_sessions/sess_pq3ch2rb598etpbf9p8i65vo03